Merck to pay Gilead $14m in attorneys’ fees

20-07-2017

A California district court has awarded Gilead Sciences $13.8 million in attorneys’ fees in a patent dispute against Merck & Co, Merck Sharp & Dohme and Isis Pharmaceuticals.


Merck, MSD, Isis Pharmaceuticals, Gilead, patent, US District Court for the Northern District of California, patent infringement,

LSIPR